Neurocrine Biosciences
Price & Volume
Stats
See moreOpen | $135.49 |
Previous Close | $135.79 |
Day Range | $132.28-$135.49 |
52W Range | $84.23-$160.18 |
Market Cap | $13.5B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $2.6B |
Revenue Growth (YoY) | 27.8% |
Gross Profit (12 Mos) | $1.6B |
Diluted EPS | $4.20 |
News
See moreYahoo Finance • 21 days ago
Neurocrine : Phase 3 Study Of Valbenazine In Dyskinetic Cerebral Palsy Fails To Meet Main Goal
Yahoo Finance • 2 months ago
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally
Yahoo Finance • 2 months ago
Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings.
Yahoo Finance • 3 months ago
Goldman says these 20 overlooked stocks are poised to spike this coming earnings season
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 12780 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,800 |
